𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas

✍ Scribed by Adriana Balderas-Loaeza; Gabriela Anaya-Saavedra; Velia A. Ramirez-Amador; Miriam C. Guido-Jimenez; Mina Kalantari; Itzel E. Calleja-Macias; Hans-Ulrich Bernard; Alejandro Garcia-Carranca


Publisher
John Wiley and Sons
Year
2007
Tongue
French
Weight
191 KB
Volume
120
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Infection with human papillomavirus‐16 (HPV‐16) is the cause of most anogenital carcinomas. This virus is also detected in about 20% of all head and neck squamous cell carcinomas. While there is strong evidence for a causal etiological role in the case of tonsillar carcinomas, causal association with malignant lesions of the oral cavity is not yet conclusive. Our previous investigations of HPV‐16 DNA methylation in anogenital sites have identified hypermethylation of the L1 gene and part of the long control region in many malignant lesions, but rarely in asymptomatic infections and low‐grade precancerous lesions. Here, we report hypermethylation of this diagnostically important segment of the viral DNA in 10 out of 12 HPV‐16 positive oral carcinomas from Mexican patients. These data indicate epigenetic changes of HPV‐16 in oral carcinomas similar to those in anogenital carcinomas, suggesting carcinogenic processes under the influence of HPV‐16 in most if not all of these oral malignant lesions. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Association of p73 G4C14-to-A4T14 polymo
✍ Xuemei Ji; Erich M. Sturgis; Chong Zhao; Carol J. Etzel; Qingyi Wei; Guojun Li 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

## Abstract ## BACKGROUND: The tumor protein p73 interacts with the human papillomavirus type 16 (HPV‐16) oncoproteins E6 and E7, and __p73__ variation may modify the interaction between p73 protein and HPV‐16 oncogenic proteins and contribute to cellular malignant transformation. ## METHODS: In